(EMAILWIRE.COM, December 07, 2019 ) Top-down and bottom-up approaches were used to validate the size of the global embolic protection device market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues were determined through primary and secondary research.

The growth in Embolic Protection Devices Market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.

Market Segmentation in Detailed:

On the basis of application, the market is categorized into cardiovascular, neurovascular, and peripheral vascular diseases. The neurovascular segment is expected to grow at the highest CAGR during the forecast period. The favorable medical reimbursement scenarios for neurovascular procedures in developed countries, increasing awareness about the clinical efficacy of embolic protection devices among neurosurgeons.

On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global market.

The major end users of Embolic Protection Devices Market are hospitals and ambulatory surgical centers. The hospital segment is expected to grow at the highest CAGR during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures performed in hospitals.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803

Geographic Analysis:

• Further breakdown of the Rest of Asia Pacific market into South Korea, Australia, New Zealand, and others

• Further breakdown of the Rest of Europe market into Belgium, Russia, the Netherlands, Switzerland, and others

• Further breakdown of the Rest of Latin America market into Argentina, Colombia, Chile, and others

The rising geriatric population, prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and presence of a large number of medical device product manufacturers are driving the growth of the Embolic Protection Devices Market in North America. Asia Pacific, on the other hand, is expected to grow at the highest CAGR during the forecast period due to the growing number of prescriptions for people aged 65 or above, increasing healthcare spending, rising healthcare costs, and increasing target population.


Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803

Worldwide Leading Players in Industry:

The prominent players in the Embolic Protection Devices Market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).